At the last check on Thursday, Ampio Pharmaceuticals Inc.’s (AMEX:AMPE) stock was up $0.04, moving up 23.36 percent to $0.22. The average number of shares traded per day over the past five days has been 261,900 shares. 2 times new highs have been achieved over the past 5 days, with a $0.0100 gain in that time frame. In the last twenty days, the average volume was 199,975, while in the previous 50 days, it was 532,156.
Since last month, AMPE stock retreated -5.81%. Shares of the company fell to $0.1677 on 08/04/23, the lowest level in the past month. A 52-week high of $1.90 was reached on 08/01/23 after having rallying from a 52-week low of $0.17. Since the beginning of this year, AMPE’s stock price has dropped by -3.15% or -$0.0192, and marked a new high 6 times. However, the stock has declined by -88.51% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
AMPE stock investors should be aware that Ampio Pharmaceuticals Inc. (AMPE) stock had its last reported insider trading activity 83 days ago on Jun 09. BUCHI J KEVIN, the Director of the company, purchased of 21,858 shares for $0.29 on Jun 09. It resulted in a $6,284 investment by the insider. BUCHI J KEVIN added 25,000 shares at an average price of $0.30 on Jun 08. The insider now owns 125,000 shares following the transaction. On May 24, CEO MARTINO MICHAEL A bought 76,890 shares at $0.29 apiece. The transaction was valued at $22,121.
Financial Health
In the three months ended June 29, Ampio Pharmaceuticals Inc.’s quick ratio stood at 3.70, while its current ratio was 3.70, showing that the company is able to pay off its debt.
While analysts expected Ampio Pharmaceuticals Inc. to report -$0.02 quarterly earnings, the actual figure was -$0.01 per share. The liabilities of Ampio Pharmaceuticals Inc. were 2.59 million at the end of its most recent quarter ended June 29, and its total debt was $0.45 million. The value of shareholders’ equity is $15.1 million.
Technical Picture
This quick technical analysis looks at Ampio Pharmaceuticals Inc.’s (AMPE) price momentum. With a historical volatility rate of 108.82%, the RSI 9-day stood at 55.43% on 30 August.
With respect to its five-day moving average, the current Ampio Pharmaceuticals Inc. price is up by +5.10% percent or $0.0100. At present, AMPE shares trade -2.42% below its 20-day simple moving average and -6.79% percent below its 100-day simple moving average. However, the stock is currently trading approximately -15.57% below its SMA50 and -44.32% below its SMA200.
Stochastic coefficient K was 31.77% and Stochastic coefficient D was 13.41%, while ATR was 0.0197. Given the Stochastic reading of 80.00% for the 14-day period, the RSI (14) reading has been calculated as 49.99%.
Analyst Ratings
Ampio Pharmaceuticals Inc. (AMPE) has been rated Hold by analysts. According to 0 brokerage firms, AMPE is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Ampio Pharmaceuticals Inc. stock as buy, with 0 recommending it as overweight.
With a median target price of $30.00, the current consensus forecast for the stock is $30.00 – $30.00. Based on these forecasts, analysts predict Ampio Pharmaceuticals Inc. (AMPE) will achieve an average price target of $30.00.
